{"id":"https://genegraph.clinicalgenome.org/r/0203c448-5004-4931-8071-d976ea671859v1.0","type":"EvidenceStrengthAssertion","dc:description":"*DHCR24* was first reported in relation to autosomal recessive desmosterolosis in 2001 (Waterham et al., PMID: 11519011). This condition can include developmental delay, intellectual disability, brain abnormalities including decreased white matter, agenesis of the corpus callosum, and seizures. There may also be dysmorphic facial features, heart defects, and limb abnormalities. Prenatal features of this condition may include cystic hygroma, skin edema, ventriculomegaly, and joint contractures.\nNine unique variants (missense, nonsense, canonical splice site) that have been reported in six probands in five publications (PMIDs: 11519011, 21559050, 21671375, 33027564, 38239854) are included in this curation. The mechanism of pathogenicity is reported to be loss of function. This gene-disease relationship is also supported by animal models, expression studies, and functional alteration studies (PMIDs: 21845517, 30891795, 25637936). Null mouse models recapitulate the rhizomelic limb shortening that has been observed in humans. Abnormal neuronal morphology has also been observed in null mouse models. \nIn summary, there is definitive evidence supporting the relationship between *DHCR24* and autosomal recessive desmosterolosis. This has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time. This classification was approved by the ClinGen Prenatal GCEP on June 25, 2025 (SOP Version 11). ​","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/0203c448-5004-4931-8071-d976ea671859","GCISnapshot":"https://genegraph.clinicalgenome.org/r/c0bfe726-6062-406f-bbcf-ccd1f21ba987","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/c0bfe726-6062-406f-bbcf-ccd1f21ba987_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10106","date":"2025-10-03T18:22:39.142Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/c0bfe726-6062-406f-bbcf-ccd1f21ba987_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10106","date":"2025-06-25T16:00:00.000Z","role":"Approver"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c0bfe726-6062-406f-bbcf-ccd1f21ba987_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/be3e1a7c-da9a-4fd6-9d0f-bc25f48c62e0_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5a48813f-3252-4f2f-a1e4-e4d5e5b4bdb6","type":"EvidenceLine","dc:description":"Deducted points for homozygosity","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5a48813f-3252-4f2f-a1e4-e4d5e5b4bdb6_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Created a molecular dynamics simulation. The M169T variant (located in the putative FAD-binding site) showed the most dramatic impact on FAD based on the number of dropped interactions compared to WT; other variants previously reported in patients also showed disrupted interactions​.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/5a48813f-3252-4f2f-a1e4-e4d5e5b4bdb6_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/38239854","allele":{"id":"https://genegraph.clinicalgenome.org/r/f8fcd189-b79b-477a-87a0-44258a356814","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014762.4(DHCR24):c.506T>C (p.Met169Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA22765294"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/be3e1a7c-da9a-4fd6-9d0f-bc25f48c62e0","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/38239854","rdfs:label":"Cocciadiferro 2024: Proband","ageType":"AgeAtOnset","ageUnit":"WeeksGestation","ageValue":20,"allele":{"id":"https://genegraph.clinicalgenome.org/r/f8fcd189-b79b-477a-87a0-44258a356814"},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Prenatal findings on 20w US: bilateral ventriculomegaly (confirmed by fetal MRI)​.\n\nBorn at term, feeding difficulties, hypotonia, EEG showed generalized parenchymal atrophy, reduced frontal and temporal operculatization, hypoplasia of corpus callosum, basal ganglia, thalami, spinal cord, severe failure to thrive, developmental delay, spastic quadriplegia (progressive), visual impairment, seizures. \n\nAt 8y MRI showed progression of cerebral and cerebellar atrophy​.\n\nAt 11y: coarse facial features, relative macrocephaly with metopic suture prominence and scapho-dolichocephaly, thick eyelashes, bilateral epicanthus with mild down-slanting palpebral fissures, bulbous nose tip, slightly anteverted nostrils with prominent columella, long philtrum with a thin upper lip, retrognathia​.​\n\nOldest child of parents was stillborn at 8m GA “likely due to unspecified fetal malformations and anhydramnios”​.​\n\nSterol quantitation via GC/MS showed elevated desmosterol​\n\nNo known consanguinity​","phenotypes":["obo:HP_0000414","obo:HP_0025102","obo:HP_0000268","obo:HP_0002478","obo:HP_0011231","obo:HP_0002120","obo:HP_0001252","obo:HP_0011968","obo:HP_0000463","obo:HP_0010761","obo:HP_0000494","obo:HP_0000219","obo:HP_0000343","obo:HP_0005487","obo:HP_0002079","obo:HP_0000301","obo:HP_0004482","obo:HP_0002119","obo:HP_0007370","obo:HP_0001272","obo:HP_0002283"],"previousTesting":true,"previousTestingDescription":"Karyotype: 46,XX; Microarray normal, negative sequencing for 8 gene panel associated with pyruvate dehydrogenase complex defects.","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/5a48813f-3252-4f2f-a1e4-e4d5e5b4bdb6_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/c6103c98-7269-488f-9866-e2223d5c59a7_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/52adaa81-0c44-4827-b457-b6ce550ae6c5","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/52adaa81-0c44-4827-b457-b6ce550ae6c5_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Variants expressed separately in S. cerevisiae (lacks endogenous sterol-delta24-reductase activity so not capable of cholesterol synthesis). Incubation with desmosterol showed significant decrease in variant enzyme activity compared to WT (Fig. 4) – Arg94His showed ~20% cholesterol production compared to WT.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/52adaa81-0c44-4827-b457-b6ce550ae6c5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21671375","allele":{"id":"https://genegraph.clinicalgenome.org/r/884ee792-a6b7-458a-b788-606c3ac81881","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014762.4(DHCR24):c.281G>A (p.Arg94His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA129348"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/515d1bce-1c1b-47d4-82a1-7c7cbb7046d8","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/515d1bce-1c1b-47d4-82a1-7c7cbb7046d8_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Variants expressed separately in S. cerevisiae (lacks endogenous sterol-delta24-reductase activity so not capable of cholesterol synthesis). Incubation with desmosterol showed significant decrease in variant enzyme activity compared to WT (Fig. 4) – Glu480Lys showed ~25% cholesterol production compared to WT.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/515d1bce-1c1b-47d4-82a1-7c7cbb7046d8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21671375","allele":{"id":"https://genegraph.clinicalgenome.org/r/c6bac1f0-3109-477c-9bbb-59cca8dc4eac","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014762.4(DHCR24):c.1438G>A (p.Glu480Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA129350"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/c6103c98-7269-488f-9866-e2223d5c59a7","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21671375","rdfs:label":"Schaaf 2011: Proband","ageType":"AgeAtOnset","ageUnit":"WeeksGestation","ageValue":34,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/884ee792-a6b7-458a-b788-606c3ac81881"},{"id":"https://genegraph.clinicalgenome.org/r/c6bac1f0-3109-477c-9bbb-59cca8dc4eac"}],"detectionMethod":"Candidate gene sequencing based on biochemical testing","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Born at 34w via SVD, late antenatal care with first US at 1 day prior to delivery – showed hydrocephalus, ACC, arthrogryposis, retrognathia; \nAt birth: macrocephaly, prominent forehead, metopism. Dysmorphic features: telecanthus, short nose with anteverted nares, low-set ears, mild arthrogryposis, bilateral 5th finger clinodactyly, mild cutaneous 2-4 toe syndactyly, proximal placement of great toes. Brain MRI at 3 DOL: enlarged lateral and third ventricles, thickening of tectum and massa intermedia, dysmorphic lateral ventricles, absent septum pellucidum, open sylvian fissure, thinned corpus callosum.\nDevelopmental delay at 8 months, shortening of all extremities.","phenotypes":["obo:HP_0009826","obo:HP_0000369","obo:HP_0000278","obo:HP_0003196","obo:HP_0005490","obo:HP_0000463","obo:HP_0000256","obo:HP_0002079","obo:HP_0002804","obo:HP_0004209","obo:HP_0001263","obo:HP_0007082","obo:HP_0010055","obo:HP_0000506","obo:HP_0001274","obo:HP_0001331","obo:HP_0011220"],"previousTesting":true,"previousTestingDescription":"Karyotype 46,XX","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/515d1bce-1c1b-47d4-82a1-7c7cbb7046d8_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/52adaa81-0c44-4827-b457-b6ce550ae6c5_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/41da8fb5-509c-4288-943f-e475b182ab08_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/17be9b65-3bfd-433e-bb02-b97b4e3a1771","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/17be9b65-3bfd-433e-bb02-b97b4e3a1771_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33027564","allele":{"id":"https://genegraph.clinicalgenome.org/r/fb3c28cc-f597-4fb6-8db0-4ccdf57182cf","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014762.4(DHCR24):c.1218+1G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA22749207"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/99e34294-ad1d-4bb2-9108-8894f01132f4","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/99e34294-ad1d-4bb2-9108-8894f01132f4_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33027564","allele":{"id":"https://genegraph.clinicalgenome.org/r/370c5ac9-4867-4cd9-8e9e-38054d1b75d5","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014762.4(DHCR24):c.1204C>T (p.Gln402Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA340451640"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/41da8fb5-509c-4288-943f-e475b182ab08","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33027564","rdfs:label":"Sparks 2020: H083","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":0,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/370c5ac9-4867-4cd9-8e9e-38054d1b75d5"},{"id":"https://genegraph.clinicalgenome.org/r/fb3c28cc-f597-4fb6-8db0-4ccdf57182cf"}],"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Cystic hygroma, skin edema, abnormal skull shape, abnormal extremity contractures, included in study of NIFH. Pregnancy was terminated.","phenotypes":["obo:HP_0000240","obo:HP_0000476","obo:HP_0002828","obo:HP_0000969"],"previousTesting":true,"previousTestingDescription":"Non-diagnostic karyotype or array","sex":"UnknownEthnicity","variant":[{"id":"https://genegraph.clinicalgenome.org/r/99e34294-ad1d-4bb2-9108-8894f01132f4_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/17be9b65-3bfd-433e-bb02-b97b4e3a1771_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/15cea90f-397b-4473-a240-94ff781d6513_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/54ebcde0-f1d7-4aaa-9fa9-c6772200c9cc","type":"EvidenceLine","dc:description":"Points deducted for consanguinity/homozygosity","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/54ebcde0-f1d7-4aaa-9fa9-c6772200c9cc_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Markedly increased desmosterol levels compared to control and carrier father (120-fold increase compared to 1.5-fold increase for carrier father)\n","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/54ebcde0-f1d7-4aaa-9fa9-c6772200c9cc_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21559050","allele":{"id":"https://genegraph.clinicalgenome.org/r/cea7e7b2-2d00-4774-96ea-1cb9958ffa4a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014762.4(DHCR24):c.307C>T (p.Arg103Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA129346"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/15cea90f-397b-4473-a240-94ff781d6513","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21559050","rdfs:label":"Zolotushko 2011: VI","ageType":"AgeAtReport","ageUnit":"Years","ageValue":6,"allele":{"id":"https://genegraph.clinicalgenome.org/r/cea7e7b2-2d00-4774-96ea-1cb9958ffa4a"},"firstTestingMethod":"Linkage analysis","phenotypeFreeText":"microcephaly, microretrognathia, psychomotor retardation, spasticity with contractures of hands, partial/full agenesis of corpus callosum, ventriculomegaly with thinning white matter, strabismus and nystagmus, convulsions, FTT","phenotypes":["obo:HP_0012430","obo:HP_0000486","obo:HP_0000308","obo:HP_0001263","obo:HP_0000252","obo:HP_0001257","obo:HP_0001274","obo:HP_0009473","obo:HP_0001508","obo:HP_0002119","obo:HP_0000639"],"previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/54ebcde0-f1d7-4aaa-9fa9-c6772200c9cc_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/9914c701-a827-4d3f-933e-f6a7959f44a5_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1e394b1d-9fd4-4060-a122-4acc3f1aefd8","type":"EvidenceLine","dc:description":"Recurrent variant (PMIDs: 24961299, 29175559, 36538928), but did not increase points from default as variant is homozygous.","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1e394b1d-9fd4-4060-a122-4acc3f1aefd8_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"All variants expressed in S. cerevisiae and the ability to convert desmosterol to cholesterol was measured. Glu191Lys showed 19.9% activity compared to WT – authors state this residual activity is consistent with the relatively milder phenotype.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/1e394b1d-9fd4-4060-a122-4acc3f1aefd8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11519011","allele":{"id":"https://genegraph.clinicalgenome.org/r/0a683335-141a-406b-bf23-613ad7063eda","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014762.4(DHCR24):c.571G>A (p.Glu191Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA116779"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/9914c701-a827-4d3f-933e-f6a7959f44a5","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11519011","rdfs:label":"Waterham 2001: Patient 2","ageType":"AgeAtReport","ageUnit":"Years","ageValue":4,"allele":{"id":"https://genegraph.clinicalgenome.org/r/0a683335-141a-406b-bf23-613ad7063eda"},"detectionMethod":"Candidate gene sequencing based on biochemical testing.","ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Dysmorphic facial features, microcephaly, limb anomalies, profound developmental delay (reported by Andersson 2000 and in PMID 12457401), dx of desmosterolosis based on biochemical testing. No known prenatal findings.","phenotypes":["obo:HP_0000494","obo:HP_0001776","obo:HP_0000252","obo:HP_5201016","obo:HP_0000286","obo:HP_0009473","obo:HP_0012736"],"previousTesting":false,"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/1e394b1d-9fd4-4060-a122-4acc3f1aefd8_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/53c45767-cc06-4bf3-8e4a-fe71ddb44d7c_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/10c009a8-743a-4454-8635-26ed212e8a6b","type":"EvidenceLine","dc:description":"Complex allele has been reported in another patient (PMID 26275793)​","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/10c009a8-743a-4454-8635-26ed212e8a6b_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"All variants expressed in S. cerevisiae and the ability to convert desmosterol to cholesterol was measured. N294T + K306N complex allele showed 0.8% DHCR24 activity compared to WT; whereas N294T showed 14.4% and K306N showed 49.8% - authors concluded that the combination of N297T and K306N was necessary for complete deficiency. ​","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/10c009a8-743a-4454-8635-26ed212e8a6b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11519011","allele":{"id":"https://genegraph.clinicalgenome.org/r/1af6d76a-ff22-4dbf-901b-a4992437853a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014762.3(DHCR24):c.[881A>C,918G>C]","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/4368"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/68aa4b2c-41a3-46b8-85b8-14ddc7fdef26","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/68aa4b2c-41a3-46b8-85b8-14ddc7fdef26_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Variant expressed in S. cerevisiae and the ability of the mutant to convert desmosterol to cholesterol was measured. Tyr471Ser showed no activity.​","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/68aa4b2c-41a3-46b8-85b8-14ddc7fdef26_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11519011","allele":{"id":"https://genegraph.clinicalgenome.org/r/509b2946-b674-40d4-a8bd-41c954de6ce2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014762.4(DHCR24):c.1412A>C (p.Tyr471Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA116778"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/53c45767-cc06-4bf3-8e4a-fe71ddb44d7c","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11519011","rdfs:label":"Waterham 2001: Patient 1​","ageType":"AgeAtReport","ageUnit":"WeeksGestation","ageValue":34,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/509b2946-b674-40d4-a8bd-41c954de6ce2"},{"id":"https://genegraph.clinicalgenome.org/r/1af6d76a-ff22-4dbf-901b-a4992437853a"}],"detectionMethod":"Candidate gene sequencing based on biochemical diagnosis","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Non-consanguineous parents, born at 34w GA, died 1h after birth.​\nMacrocephaly, frontal bossing, hypoplastic nose, posteriorly rotated low-set ears, cleft palate, micrognathia, ambiguous genitalia, rhizomelic shortening of limbs, malformation of several internal organs, generalized osteosclerosis, diagnosis of desmosterolosis based on biochemical testing. No known prenatal findings.​","phenotypes":["obo:HP_0000358","obo:HP_0008905","obo:HP_0000347","obo:HP_0000175","obo:HP_0005789","obo:HP_0003196","obo:HP_0000369","obo:HP_0002007","obo:HP_0000062","obo:HP_0000256"],"previousTesting":false,"sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/10c009a8-743a-4454-8635-26ed212e8a6b_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/68aa4b2c-41a3-46b8-85b8-14ddc7fdef26_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":7.5},{"id":"https://genegraph.clinicalgenome.org/r/c0bfe726-6062-406f-bbcf-ccd1f21ba987_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c0bfe726-6062-406f-bbcf-ccd1f21ba987_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e25d1baf-3c43-4ee2-bae8-2ee0e2d3b4b1","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8e351d53-eabb-41b9-b2e0-bf6d4c71f5ec","type":"Finding","dc:description":"Short limbs have been observed in humans","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30891795","rdfs:label":"Allen KO Mouse Model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/222ed690-112e-4d76-abdb-dd55d63ef052","type":"EvidenceLine","dc:description":"Phenotype seen in another mouse study. This model provides evidence in a separate mouse model and focuses specifically on bone pathology.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dead7e5f-101d-4ce9-b078-776a14c73e25","type":"Finding","dc:description":"Human phenotype includes short limbs","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21845517","rdfs:label":"Mirza 2012 Mouse Model - bone phenotype","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/c0bfe726-6062-406f-bbcf-ccd1f21ba987_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/939b77c1-d7d5-4709-a086-f424cadf21b3","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8d827397-ce69-453b-8e89-a785c20057e7","type":"FunctionalAlteration","dc:description":"Assessed functional consequences of interaction by using siRNA in CHO-7 cells​. Knockdown of DHCR24 and DHCR7 decreased their enzyme activity compared to control​. Knockdown of DHCR7 did not affect DHCR24 activity whereas knockdown of DHCR24 decreased DHCR7 activity by 60%​. \n\nAssessed DHCR7 activity when DHCR24 was overexpressed​. Compared DHCR7 activity in CHO-EV, CHO-DCHR24, and a ​mutant (Y471S) DHCR24 cell line​. DHCR24 activity was decreased almost completely in ​ CHO-EV and mutant cells lines  compared to CHO-DHCR24 ​cell line​. Knockdown of DHCR24 decreased DHCR7 activity in all​ cell lines​.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25637936","rdfs:label":"Luu 2015 - Functional alteration"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/c0bfe726-6062-406f-bbcf-ccd1f21ba987_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/535cac53-9e7b-48f8-98cf-49a4f14b54ff","type":"EvidenceLine","dc:description":"3 assays scored at 0.5 points each","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/be804b9f-20f3-4275-b9d1-76e2ab44ca30","type":"Finding","dc:description":"Impaired bone growth due to decreased reactive oxygen species scavenging activity.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21845517","rdfs:label":"Mirza 2012 - ROS scavenging activity","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/9fb85c52-d573-4742-ba1b-960c2c061b64","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8c8bc078-c28c-474b-91a0-43524c157dff","type":"Finding","dc:description":"Expression of DHCR24 in WT mice observed throughout the resting, proliferative, and hypertrophic zones​.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21845517","rdfs:label":"Mirza 2012 Expression in Mice","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":5.5}],"evidenceStrength":"Definitive","sequence":11931,"specifiedBy":"GeneValidityCriteria11","strengthScore":13,"subject":{"id":"https://genegraph.clinicalgenome.org/r/ulz7BwyLL-U","type":"GeneValidityProposition","disease":"obo:MONDO_0011217","gene":"hgnc:2859","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_c0bfe726-6062-406f-bbcf-ccd1f21ba987-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}